Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment September 26, 2019 2019 | Cardiology | TCT Tags: 2019, Cardiology, TCT http://tv.clinicaltrialresults.org/file_repos/45/2373-2345.mp4 Loading… Taking too long? Reload document | Open in new tab Download Disclosures: TBA Article Navigation Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: The Medically Ill Patients in AUGUSTUS Dr. Gennaro Sardella and Dr. Francesco Burzotta Present: TCT 2019 Wrap-Up in Italian
Reload document 
Open in new tab